My Journal Implant scheduled for Sept 3rd 2019

[LewisNews]

Endo Pharmacauticals has discontinued XIAFLEX Collagenase Clostridium Histolyticum (CCH) injection in Australia and Asia, and plans to do the same to whole Europe by the end of 2019. The American laboratory has decided to withdraw it for economic reasons. As a result, the drug is no longer available except in the US and Canada. Now the only treatment options for Peyronie´s disease are surgery or Penile Traction Device (alone or combined with PRP), in the rest of the world. See official letter

http://dupuytrenssociety.blogspot.com/2 ... inued.html